• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

False-positive COVID-19 results: hidden problems and costs.

作者信息

Surkova Elena, Nikolayevskyy Vladyslav, Drobniewski Francis

机构信息

Royal Brompton Hospital, Royal Brompton and Harefield National Health Service Foundation Trust, London SW3 6NP, UK.

Imperial College London, London, UK.

出版信息

Lancet Respir Med. 2020 Dec;8(12):1167-1168. doi: 10.1016/S2213-2600(20)30453-7. Epub 2020 Sep 29.

DOI:10.1016/S2213-2600(20)30453-7
PMID:33007240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524437/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25a/7524437/2b3e82f71b63/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25a/7524437/2b3e82f71b63/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25a/7524437/2b3e82f71b63/fx1_lrg.jpg

相似文献

1
False-positive COVID-19 results: hidden problems and costs.新冠病毒检测假阳性结果：潜在问题与成本
Lancet Respir Med. 2020 Dec;8(12):1167-1168. doi: 10.1016/S2213-2600(20)30453-7. Epub 2020 Sep 29.
2
Interpretation of COVID-19 PCR testing- what surgeons need to know.新型冠状病毒肺炎聚合酶链反应检测的解读——外科医生需要了解的内容。
Br J Surg. 2020 Sep;107(10):e367. doi: 10.1002/bjs.11804. Epub 2020 Jul 20.
3
Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries.2019冠状病毒病的筛查：低收入和中等收入国家的卫生政策影响
Mayo Clin Proc. 2020 Dec;95(12):2606-2608. doi: 10.1016/j.mayocp.2020.10.007. Epub 2020 Oct 15.
4
SARS-CoV-2 Nasopharyngeal Swab Testing-False-Negative Results From a Pervasive Anatomical Misconception.严重急性呼吸综合征冠状病毒2型鼻咽拭子检测——普遍存在的解剖学误解导致的假阴性结果
JAMA Otolaryngol Head Neck Surg. 2020 Nov 1;146(11):993-994. doi: 10.1001/jamaoto.2020.2946.
5
Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection.评估新开发的用于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）分子检测的BioFire COVID-19检测方法。
Clin Microbiol Infect. 2020 Dec;26(12):1699-1700. doi: 10.1016/j.cmi.2020.07.026. Epub 2020 Jul 28.
6
False Positive Results With SARS-CoV-2 RT-PCR Tests and How to Evaluate a RT-PCR-Positive Test for the Possibility of a False Positive Result.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）逆转录聚合酶链反应（RT-PCR）检测的假阳性结果以及如何评估RT-PCR阳性检测结果出现假阳性的可能性
J Occup Environ Med. 2021 Mar 1;63(3):e159-e162. doi: 10.1097/JOM.0000000000002138.
7
Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident.在养老院一名居民出现首例新冠病毒病（COVID-19）后，对接受医疗照护的养老院工作人员进行鼻咽部逆转录聚合酶链反应（RT-PCR）系统筛查的效果有限。
Med Mal Infect. 2020 Nov;50(8):748-750. doi: 10.1016/j.medmal.2020.04.020. Epub 2020 May 4.
8
Negative results in nucleic acid test of COVID-19 patients: assessment from the perspective of clinical laboratories.新冠肺炎患者核酸检测阴性结果：临床实验室角度评估。
Ann Palliat Med. 2020 Nov;9(6):4246-4251. doi: 10.21037/apm-20-568. Epub 2020 Sep 14.
9
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low.模糊中的准确性：COVID-19流行率较低时SARS-CoV-2核酸检测的假阳性结果
Pathology. 2020 Dec;52(7):809-811. doi: 10.1016/j.pathol.2020.09.009. Epub 2020 Sep 30.
10
Measures to Avoid Exogenous RNA Contamination of NCP Nucleic Acid Detection.避免新型冠状病毒核酸检测中外源性RNA污染的措施。
Clin Lab. 2020 May 1;66(5). doi: 10.7754/Clin.Lab.2020.200401.

引用本文的文献

1
Impact of a New SARS-CoV-2 Variant on the Population: A Mathematical Modeling Approach.一种新型严重急性呼吸综合征冠状病毒2变体对人群的影响：一种数学建模方法。
Math Comput Appl. 2021 Jun;26(2). doi: 10.3390/mca26020025. Epub 2021 Mar 27.
2
Innovation landscape in nanobiosensors for COVID-19 detection and future implications for a resilient Global Health Security.用于新冠病毒检测的纳米生物传感器创新格局及其对全球卫生安全韧性的未来影响。
3 Biotech. 2025 Jun;15(6):170. doi: 10.1007/s13205-025-04342-1. Epub 2025 May 15.
3
Learn from the SARS-CoV-2 nucleic acid test to increase the experience of dealing with the "disease X ".

本文引用的文献

1
False-negative results of initial RT-PCR assays for COVID-19: A systematic review.COVID-19 初始 RT-PCR 检测的假阴性结果：系统评价。
PLoS One. 2020 Dec 10;15(12):e0242958. doi: 10.1371/journal.pone.0242958. eCollection 2020.
2
Interpreting a covid-19 test result.解读新冠病毒检测结果。
BMJ. 2020 May 12;369:m1808. doi: 10.1136/bmj.m1808.
3
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.通过细胞培养测定病毒 RNA 载量作为管理工具，以将 SARS-CoV-2 患者从传染病病房中出院。
从新冠病毒核酸检测中吸取经验，以增加应对“X疾病”的经验。
BMC Infect Dis. 2025 Apr 24;25(1):593. doi: 10.1186/s12879-025-10991-7.
4
A Truncated Multi-Thiol Aptamer-Based SARS-CoV-2 Electrochemical Biosensor: Towards Variant-Specific Point-of-Care Detection with Optimized Fabrication.一种基于截短多硫醇适配体的新型冠状病毒2型电化学生物传感器：通过优化制备实现变异株特异性即时检测
Biosensors (Basel). 2025 Jan 6;15(1):24. doi: 10.3390/bios15010024.
5
Inverse-designed waveguide-based biosensor for high-sensitivity, single-frequency detection of biomolecules.用于生物分子高灵敏度单频检测的基于逆设计波导的生物传感器。
Nanophotonics. 2022 Mar 1;11(7):1427-1442. doi: 10.1515/nanoph-2022-0012. eCollection 2022 Mar.
6
Strategies to Overcome Erroneous Outcomes in Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Testing: Insights From the COVID-19 Pandemic.克服逆转录聚合酶链反应（RT-PCR）检测错误结果的策略：来自COVID-19大流行的见解
Cureus. 2024 Nov 3;16(11):e72954. doi: 10.7759/cureus.72954. eCollection 2024 Nov.
7
Feasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India).使用可穿戴传感器进行快速检测以发现心肺疾病（印度的新冠感染情况）的可行性。
NPJ Digit Med. 2024 Oct 19;7(1):289. doi: 10.1038/s41746-024-01287-2.
8
The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis.循环 microRNAs 作为 COVID-19 新型诊断生物标志物的潜力：系统评价和荟萃分析。
BMC Infect Dis. 2024 Sep 19;24(1):1011. doi: 10.1186/s12879-024-09915-8.
9
Relationship between Underlying Diseases with Morbidity and Mortality in Patients with COVID-19.新型冠状病毒肺炎患者基础疾病与发病率和死亡率的关系
Tanaffos. 2023 Apr;22(4):433-439.
10
Screening multi-dimensional heterogeneous populations for infectious diseases under scarce testing resources, with application to COVID-19.在检测资源稀缺的情况下对多维度异质人群进行传染病筛查，并应用于新冠肺炎。
Nav Res Logist. 2022 Feb;69(1):3-20. doi: 10.1002/nav.21985. Epub 2021 Mar 16.
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061. doi: 10.1007/s10096-020-03913-9. Epub 2020 Apr 27.